Safety and Efficacy of Hypothermia (34°C) after Hemicraniectomy for Malignant MCA Infarction
10.3340/jkns.2016.1111.002
- Author:
Hyun Seok PARK
1
;
Jae Hyung CHOI
Author Information
1. Department of Neurosurgery, Busan-Ulsan Regional Cardio-Cerebrovascular Center, Medical Science Research Center, Dong-A University College of Medicine, Busan, Korea. nsparkhs@dau.ac.kr
- Publication Type:Original Article
- Keywords:
Hypothermia;
Decompressive craniecotmy;
Cerebral infarction;
Middle cerebral artery;
Brain edema;
Mortality
- MeSH:
Arrhythmias, Cardiac;
Brain Edema;
Cerebral Infarction;
Glasgow Coma Scale;
Hemorrhage;
Humans;
Hypotension;
Hypothermia;
Infarction;
Infarction, Middle Cerebral Artery;
Logistic Models;
Middle Cerebral Artery;
Mortality;
National Institutes of Health (U.S.);
Pneumonia;
Postoperative Care;
Prognosis;
Retrospective Studies;
Sepsis;
Stroke;
Treatment Outcome
- From:Journal of Korean Neurosurgical Society
2018;61(2):267-276
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The beneficial effect of hypothermia after hemicraniectomy in malignant middle cerebral artery (MCA) infarction has been controversial. We aim to investigate the safety and clinical efficacy of hypothermia after hemicraniectomy in malignant MCA infarction.METHODS: From October 2012 to February 2016, 20 patients underwent hypothermia (Blanketrol III, Cincinnati Sub-Zero, Cincinnati, OH, USA) at 34°C after hemicraniectomy in malignant MCA infarction (hypothermia group). The indication of hypothermia included acute cerebral infarction >2/3 of MCA territory and a Glasgow coma scale (GCS) score < 11 with a midline shift >10 mm or transtentorial herniation sign (a fixed and dilated pupil). We retrospectively collected 27 patients, as the control group, who had undergone hemicraniectomy alone and simultaneously met the inclusion criteria of hypothermia between January 2010 and September 2012, before hypothermia was implemented as a treatment strategy in Dong-A University Hospital. We compared the mortality rate between the two groups and investigated hypothermia-related complications, such as postoperative bleeding, pneumonia, sepsis and arrhythmia.RESULTS: The age, preoperative infarct volume, GCS score, National institutes of Health Stroke Scale score, and degree of midline shift were not significantly different between the two groups. Of the 20 patients in the hypothermia group, 11 patients were induced with hypothermia immediately after hemicraniectomy and hypothermia was initiated in 9 patients after the decision of hypothermia during postoperative care. The duration of hypothermia was 4±2 days (range, 1 to 7 days). The side effects of hypothermia included two patients with arrhythmia, one with sepsis, one with pneumonia, and one with hypotension. Three cases of hypothermia were discontinued due to these side effects (one sepsis, one hypotension, and one bradycardia). The mortality rate of the hypothermia group was 15.0% and that of the control group was 40.7% (p=0.056). On the basis of the logistic regression analysis, hypothermia was considered to contribute to the decrease in mortality rate (odds ratio, 6.21; 95% confidence interval, 1.04 to 37.05; p=0.045).CONCLUSION: This study suggests that hypothermia after hemicraniectomy is a viable option when the progression of patients with malignant MCA infarction indicate poor prognosis.
